Statin use and pancreatic cancer risk in two prospective cohort studies

BACKGROUND: Statins, 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors, are common lipid-lowering agents and may reduce the risk of several cancer types including pancreatic cancer. However, the association between statin use and pancreatic cancer risk has not been fully evaluated...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Gastroenterol
Main Authors: Hamada, Tsuyoshi, Khalaf, Natalia, Yuan, Chen, Babic, Ana, Morales-Oyarvide, Vicente, Qian, Zhi Rong, Nowak, Jonathan A., Ng, Kimmie, Kraft, Peter, Rubinson, Douglas A., Stampfer, Meir J., Giovannucci, Edward L., Fuchs, Charles S., Ogino, Shuji, Wolpin, Brian M.
Formato: Artigo
Idioma:Inglês
Publicado em: 2018
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7609961/
https://ncbi.nlm.nih.gov/pubmed/29362938
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00535-018-1430-x
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados